Tecnovatica S.A.

zł 0.43As of Sun 8 Nov 2026, 12:00 UTC
WSE:TECHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR 5.10%
Div yield —
ROE (2.05%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.39
PE TTM —
TSR TTM 56.16%
Mkt cap zł 15.10M
ROIC (1.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 0.482
11.94%
(43.98%)
Buy 12|8|11|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.01
0.01
0.01
0.01
14.42%
(0.68%)
1.17%
(2.05%)
Revenuezł M
0.934
0.966
0.980
1.004
7.59%
12.66%
9.17%
12.76%
Peers (US$3.814M)
Cap (US$)
PE
7.876M
—
3.756M
—
Capital
TTM
5Y
10Y
Leveragex
1.233
3.285
2.156
EBIT/Intx
2.316
0.250
0.263
Own earn%
(17.75)
37.98
33.29
Sh yield%
26.18
33.30
29.90
Owners
Insiders/Inst%
8.67
79.62
Short interest%
3.36
SBC / revenue%
1.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
13–20
$1 testx
0.0
Incr. ROIC%
13